HEALTH OF WOMAN. 2015.8(104):89–92; doi 10.15574/HW.2015.104.89 

Clinico-morphological diagnosis of adenocarcinoma of the cervix during endophytic growth form (clinical cases) 

Nespradko S. V., Melnyk M. M.

The National Cancer Institute Ministry of health of Ukraine, Kyiv

The National children's specialized hospital «OKHMATDYT» MH of Ukraine, Kyiv 

Description of the clinical case indicates low informative value of the individual methods of diagnosis by endophytic form of cervical adenocarcinoma (ACC), but the integrated use of morphological (cytological, histochemical, immunohistochemical), enzyme immunoassay, molecular-genetic methods and radiation techniques (MRI, ULTRASOUND) allow you to install this type of carcinoma. 

Key words: adenocarcinoma, cervix cancer, diagnosis, treatment. 

REFERENCES

1. Саргсян СА, Кузнецов ВВ, Бабанов МА и др. 2006. Аденокарцинома шейки матки. Вестн. РОНЦ им. НН Блохина 17;3:43–48.

2. Бохман ЯВ. 2002. Руководство по онкогинекологии. СПб, «ООО Издательство Фоллиант»:542.

3. Кондриков НИ. 2008. Патология матки. М, Практическая медицина:334.

4. Лекции по онкогинекологии: учеб. для студентов. Под общ. ред. акад. РАН и РАМН МИ Давыдова, проф. ВВ Кузнецова; под. ред. ВМ Нечушкиной. М, МЕДпресс-информ. 2009:432.

5. Федоренко ЗП, Гулак ЛО, Михайлович ЮЙ та інші. 2014. Рак в Україні 2012–2013: захворюваність, смертність показники діяльності онкологічної служби. Бюлетень Національного канцер-реєстру України 15:9.

6. Филатова НС, Винокуров ВЛ, Ефимов ДА. 1997. Результаты лечения рецидивов рака шейки матки. Казан. мед. журн. 3:211–212.

7. Харитонова ТВ. 2004. Рак шейки матки: актуальность проблемы, принципы лечения. Современ. онкология 6;2:55–61.

8. Diagnostic Immunohistochemistry edited by David J. Dabbs, Churchill Livingstone Elsevier. 2006:828.

9. Feifei G, Yali H, Xiaofeng X et al. 2013. Diagnostic challenges in minimal deviation adenocarcinoma of the uterine cervix: A report of two cases and review of the literature. Mol. Clin Oncol. 1;5:833–838.

10. Kelass-Sleczka S, Bialas B, Szlag M et al. 2013. High- dose-rate interstitial brachytherapy for mucinous endocervical-type – a case study. Ginecol. Pol. 84;12:1059–1063.

11. Thaer K, Dongfeng T, Jianmin W et al. 2006. Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma. Clin. Pathol. 6:1.

12. Tsuboyama T, Yamamoto K, Nakai G et al. 2015. A case of gastric-type adenocarcinoma of the uterine cervix associated with lobular endocervical glandular hyperplasia: radiologic- pathologic correlation. Abdom. Imaging 3:459–465. http://dx.doi.org/10.1007/s00261-014-0323-6; PMid:25504516

13. WHO Classification Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs edited by Fattaneh A. Tavassoli, Peter Devilee, IARS Press: Lyon 2003:425.

14. Yuko N, Takeshi F, Kenji I et al. 2014. Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report. Oncol. Lett. 8;6:2481–2484.